Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on PF 06463922 Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109081810A details a robust 7-step synthesis for Lorlatinib intermediates. Achieves high purity and scalable production for global pharmaceutical supply chains.
Novel 8-step synthesis of 5-fluoro-3-methylisobenzofuranone from phthalimide. High yield, low cost route for Laratinib intermediate suitable for commercial scale-up.